On June 11, 2021, the opening ceremony of Oceanpine Capital invested company——Immune Onc (Hangzhou) Co., Ltd. was successfully held in Hangzhou Biotechnology Valley Lingkong Dongchuang Innovation Center. Immune-Onc is a wholly owned subsidiary of Immune-Onc Therapeutics, Inc. in China. The landing in China this time is one of Immune-Onc's global promotion and expansion of the first innovative drug product pipeline.
Source: Oceanpine Capital
